FIELD: medicine, in particular clinical pharmacology and replacement therapy.
SUBSTANCE: claimed agent represents concentrated complex of biologically active substances derived form brown algae and contains (%): lipids 80-90, including PUFA 26.7-38.7 based on total fatty acids; mannitol 3-6; nitrogen-containing substances 1-2 %; biogenic micro- and macroelements including K, Ca, Mg, Mn, Co, Cu, Se, Ag, I in mineral and organic bonded forms 5-12. Claimed agent in useful in prophylaxis of cardiovascular and others pathologies associated with disturbance of lipid metabolism.
EFFECT: enhanced assortment of natural-origin agents with excellent antioxidant effect.
7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION BEING OF LIPID-CORRECTING, HYPOCOAGULATIVE AND ANTIOXIDANT PROPERTIES | 2005 |
|
RU2302248C2 |
| METHOD FOR SELECTING THERAPY FOR CORRECTING LIPID METABOLISM DISORDERS IN CHRONIC PYELONEPHRITIS PATIENTS | 2005 |
|
RU2310864C2 |
| LIPID-CORRECTING AGENT OF SEAWEED | 2021 |
|
RU2767908C1 |
| METHOD FOR PREPARING AGENT POSSESSING LIPID-CORRECTING ACTION | 2015 |
|
RU2589285C1 |
| METHOD FOR SELECTION OF REHABILITATION THERAPY FOR PATIENTS WITH CHRONICAL CHOLECYSTITIS IN REMISSION PHASE | 2007 |
|
RU2347571C2 |
| MEANS POSSESSING LIPID-CORRECTING AND IMMUNOMODULATING ACTIVITY | 2003 |
|
RU2259824C2 |
| DIETARY SUPPLEMENT AND METHOD OF ITS PRODUCTION | 2007 |
|
RU2340216C1 |
| CORRECTIVE COMPOSITION FOR PATHOLOGIC CARBOHYDRATE, LIPID DISBOLISM AND ANTIOXIDANT ORGANISM STATE INVOLVEMENT | 2008 |
|
RU2360683C1 |
| KELP PROCESSING METHOD | 2008 |
|
RU2360545C1 |
| METHOD FOR INSULIN RESISTANCE CORRECTION IN METABOLIC SYNDROME | 2009 |
|
RU2402326C1 |
